Increasing T Cell Versatility with SUPRA CARs
- PMID: 29856949
- DOI: 10.1016/j.cell.2018.05.030
Increasing T Cell Versatility with SUPRA CARs
Abstract
Chimeric antigen receptor (CAR) T cells offer a promising treatment option for advanced cancers resistant to standard therapy. Here, Cho et al. report a split-CAR design that enables the engineering of multi-feature CAR-T cells, aiming to address current challenges limiting the safety and efficacy of CAR-T cells for cancer treatment.
Copyright © 2018 Elsevier Inc. All rights reserved.
Comment on
-
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses.Cell. 2018 May 31;173(6):1426-1438.e11. doi: 10.1016/j.cell.2018.03.038. Epub 2018 Apr 26. Cell. 2018. PMID: 29706540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
